BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,660 | – | 18,000 | +149900.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 12 | -100.0% | 0.00% | – |
Q4 2021 | $205,000 | -52.0% | 38,518 | -23.9% | 0.00% | – |
Q3 2021 | $427,000 | +89.8% | 50,586 | +444.3% | 0.00% | – |
Q1 2021 | $225,000 | -70.5% | 9,293 | -61.0% | 0.00% | – |
Q4 2020 | $763,000 | – | 23,802 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |